RPT - INSIGHT-Allergan CEO Saunders warms up to drug discovery
November 06, 2015 at 07:00 AM EST
NEW YORK, Nov 6 (Reuters) - Brenton Saunders, the whiz-kid pharmaceutical executive with a reputation for being wary of the costs of early-stage drug development, says he's open to new ideas from outside and is now warming up to investing in drug discovery if it makes sense for his company.